Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 8, 1999, Pages 833-838

  Goh, Jason ^a   Coughlan, Barbara ^a   Quinn, John ^a   O'Keane, J Conor ^a   Crowe, John ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Extra hepatic manifestations; Fatigue; Fatigue Impact Scale; Hepatitis C

Indexed keywords

ANTINUCLEAR ANTIBODY; CRYOGLOBULIN; MITOCHONDRION ANTIBODY; RHEUMATOID FACTOR; SMOOTH MUSCLE ANTIBODY; THYROID ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE SEVERITY; FATIGUE; FEMALE; GLOMERULONEPHRITIS; HASHIMOTO DISEASE; HEPATITIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SJOEGREN SYNDROME;

EID: 0032773298     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199908000-00004     Document Type: Article

References (32)

1. 1 Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123:615-620.
2. 2 Merican I, Sherlock S, McIntyre N, Dusheiko GM. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med 1993; 86:119-125.
3. 3 Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463-1466.
4. 4 Nelles S, Abbey S, Stewart DE, Margulies M, Wanless IR, Heathcote EJ. Fatigue assessment in patients with hepatitis C [Abstract]. Gastroenterology 1996; 110(4):A1276.
5. 5 Mahl TC, Daniels K, Dahhan W, Donnelly K. Fatigue in patients with chronic hepatitis C [Abstract]. Gastroenterology 1996; 110:A1254.
6. 6 Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepatol 1997; 4:9-28.
7. 7 Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the Fatigue Impact Scale. Clin Infect Dis 1994; 18 (suppl 1):S79-S83.
8. 8 The Canadian Research Group. A randomised controlled trial of amantidine in fatigue associated with multiple sclerosis. Can J Neurol Sci 1987; 14:273-278.
9. 9 Huet PM, Deslauriers J. Impact of fatigue on quality of life of patients with primary biliary cirrhosis [Abstract]. Gastroenterology 1996; 110(4):A1215.
10. 10 Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-1520.
11. 11 Crowe J, Doyle C, Fielding JF, Holloway H, Keegan M, Kelleher D, et al. Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation [Abstract]. Gastroenterology 1995; 108:1054A.
12. 12 Power JP, Davidson F, O'Riordan J, Simmonds P, Yap PL, Lawlor E. Hepatitis C infection from anti-D immunoglobulin. Lancet 1995; 346:372-373.
13. 13 Quinn J, Goh J, Sachithanandan S, Clarke G, Calagy G. O'Keane JC, et al. Chronic hepatitis C genotype 1b infection: hepatic and clinical status nineteen years post-inoculation [Abstract]. Irish J Med Sci 1997; 155 (suppl 2):S14.
14. 14 Seeff LB. Natural history of hepatitis C. Hepatology 1997; 26 (suppl 1):21S-28S.
15. 15 Samuel D, Feray C, Bismuth H. Hepatitis viruses and liver transplantation. J Gastroenterol Hepatol 1997; 12:S335-S341.
16. 16 Dale JK, Di Bisceglie AM, Hoofnagle JH, Straus SE. Chronic fatigue syndrome; lack of association with hepatitis C virus infection. J Med Virol 1991; 34:119-121.
17. 17 Lee DH, Jamal H, Regenstein FG, Perrillo RP. Morbidity of chronic hepatitis Cas seen in a tertiary care medical center. Dig Dis Sci 1997; 42:186-191.
18. 18 Kroenke K, Wood DR, Mangelsdorff AD, Meier NJ, Powell JB. Chronic fatigue in primary care: prevalence, patient characteristics and outcome. JAMA 1988; 260:929-934.
19. 19 Jones EA. Fatigue associated with chronic liver disease: a riddle wrapped in a mystery inside an enigma. Hepatology 1995; 22:1606-1608.
20. 20 Singh N, Gayowski T, Wagener MM, Marino IR. Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus. Clin Transplant 1997; 11(5 Pt 1):406-411.
21. 21 Agnello V, Romain PL. Mired cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am 1996; 22:1-21.
22. 22 Wong VS, Egner W, Elsey T, Brown D, Alexander GJ. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996; 104:25-31.
23. 23 Fox RI. Clinical features, pathogenesis, and treatment of Sjogren's syndrome. Curr Opin Rheumatol 1996; 8:438-445.
24. 24 Garcia-Carrasco M, Ramos M, Cervera R, Font J, Vidal J, Munoz FJ, et al. Hepatitis C virus infection in 'primary' Sjogren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56:173-175.
25. 25 Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C, et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 39:1166-1171.
26. 26 Pawlotsky J, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia M, Andre C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122:169-173.
27. 27 Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106(5):1291-1300.
28. 28 Metcalfe RA, Ball G, Kudesia G, Weetman AP. Failure to find an association between hepatitis C virus and thyroid autoimmunity. Thyroid 1997; 7:421-424.
29. 29 Gorez E, Nakib I, Larbre H, Schneider N, Schvartz C, Delisle MJ, et al. Lack of epidemiological evidence for a link between thyroid auto-immune disease and hepatitis C virus infection. J Hepatol 1997; 26:736-739.
30. 30 Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7:481-493.
31. 31 Sachithanandan S, Fielding JF. Autoimmune disease is not a feature of hepatitis C infection in Ireland. J Clin Gastroenterol 1997; 25:522-524.
32. 32 Coughlan B, Sheehan J, Hickey A, Carr A, Crowe J. Preliminary findings from an ongoing study investigating the psychological impact of an iatrogenic hepatitis C infection on a previously healthy female population [Abstract]. Gastroenterology 1998; 114:L0120.